Cargando…

Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis

BACKGROUND & AIMS: The albumin-bilirubin (ALBI) score is calculated using serum levels of total bilirubin and albumin as a simple method to assess liver function. This study investigated the ability of baseline ALBI score/grade measurements to assess histological stage and disease progression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Yuki, Umemura, Takeji, Kimura, Takefumi, Joshita, Satoru, Hirohara, Junko, Nakano, Toshiaki, Komori, Atsumasa, Tanaka, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976453/
https://www.ncbi.nlm.nih.gov/pubmed/36873419
http://dx.doi.org/10.1016/j.jhepr.2022.100662
_version_ 1784899079536377856
author Yamashita, Yuki
Umemura, Takeji
Kimura, Takefumi
Joshita, Satoru
Hirohara, Junko
Nakano, Toshiaki
Komori, Atsumasa
Tanaka, Atsushi
author_facet Yamashita, Yuki
Umemura, Takeji
Kimura, Takefumi
Joshita, Satoru
Hirohara, Junko
Nakano, Toshiaki
Komori, Atsumasa
Tanaka, Atsushi
author_sort Yamashita, Yuki
collection PubMed
description BACKGROUND & AIMS: The albumin-bilirubin (ALBI) score is calculated using serum levels of total bilirubin and albumin as a simple method to assess liver function. This study investigated the ability of baseline ALBI score/grade measurements to assess histological stage and disease progression in individuals with primary biliary cholangitis (PBC) in a large Japanese nationwide cohort. METHODS: A total of 8,768 Japanese patients with PBC were enrolled between 1980 and 2016 from 469 institutions, among whom 83% received ursodeoxycholic acid (UDCA) only, 9% received UDCA and bezafibrate, and 8% were given neither drug. Baseline clinical and laboratory parameters were retrospectively retrieved and reviewed from a central database. Associations of ALBI score/grade with histological stage, mortality, and need for liver transplantation (LT) were evaluated using Cox proportional hazards models. RESULTS: During the median follow-up period of 5.3 years, 1,227 patients died (including 789 from liver-related causes) and 113 underwent LT. ALBI score and ALBI grade were significantly associated with Scheuer’s classification (both p <0.0001). ALBI grade 2 or 3 had significant associations with all-cause mortality or need for LT as well as liver-related mortality or need for LT according to Cox proportional hazards regression analysis (hazard ratio 3.453, 95% CI 2.942–4.052 and hazard ratio 4.242, 95% CI 3.421–5.260, respectively; both p <0.0001). Cumulative LT-free survival rates at 5 years in the ALBI grade 1, 2, and 3 groups were 97.2%, 82.4%, and 38.8%, respectively, while respective non-liver-related survival rates were 98.1%, 86.0%, and 42.0% (both p <0.0001, log-rank test). CONCLUSIONS: This large nationwide study of patients with PBC suggested that baseline measurements of ALBI grade were a simple non-invasive predictor of prognosis in PBC. IMPACT AND IMPLICATIONS: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts. This study examined the ability of albumin-bilirubin (ALBI) score/grade to estimate histological findings and disease progression in PBC by means of a large-scale nationwide cohort in Japan. ALBI score/grade were significantly associated with Scheuer’s classification stage. Baseline ALBI grade measurements may be a simple non-invasive predictor of prognosis in PBC.
format Online
Article
Text
id pubmed-9976453
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99764532023-03-02 Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis Yamashita, Yuki Umemura, Takeji Kimura, Takefumi Joshita, Satoru Hirohara, Junko Nakano, Toshiaki Komori, Atsumasa Tanaka, Atsushi JHEP Rep Research Article BACKGROUND & AIMS: The albumin-bilirubin (ALBI) score is calculated using serum levels of total bilirubin and albumin as a simple method to assess liver function. This study investigated the ability of baseline ALBI score/grade measurements to assess histological stage and disease progression in individuals with primary biliary cholangitis (PBC) in a large Japanese nationwide cohort. METHODS: A total of 8,768 Japanese patients with PBC were enrolled between 1980 and 2016 from 469 institutions, among whom 83% received ursodeoxycholic acid (UDCA) only, 9% received UDCA and bezafibrate, and 8% were given neither drug. Baseline clinical and laboratory parameters were retrospectively retrieved and reviewed from a central database. Associations of ALBI score/grade with histological stage, mortality, and need for liver transplantation (LT) were evaluated using Cox proportional hazards models. RESULTS: During the median follow-up period of 5.3 years, 1,227 patients died (including 789 from liver-related causes) and 113 underwent LT. ALBI score and ALBI grade were significantly associated with Scheuer’s classification (both p <0.0001). ALBI grade 2 or 3 had significant associations with all-cause mortality or need for LT as well as liver-related mortality or need for LT according to Cox proportional hazards regression analysis (hazard ratio 3.453, 95% CI 2.942–4.052 and hazard ratio 4.242, 95% CI 3.421–5.260, respectively; both p <0.0001). Cumulative LT-free survival rates at 5 years in the ALBI grade 1, 2, and 3 groups were 97.2%, 82.4%, and 38.8%, respectively, while respective non-liver-related survival rates were 98.1%, 86.0%, and 42.0% (both p <0.0001, log-rank test). CONCLUSIONS: This large nationwide study of patients with PBC suggested that baseline measurements of ALBI grade were a simple non-invasive predictor of prognosis in PBC. IMPACT AND IMPLICATIONS: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts. This study examined the ability of albumin-bilirubin (ALBI) score/grade to estimate histological findings and disease progression in PBC by means of a large-scale nationwide cohort in Japan. ALBI score/grade were significantly associated with Scheuer’s classification stage. Baseline ALBI grade measurements may be a simple non-invasive predictor of prognosis in PBC. Elsevier 2022-12-24 /pmc/articles/PMC9976453/ /pubmed/36873419 http://dx.doi.org/10.1016/j.jhepr.2022.100662 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Yamashita, Yuki
Umemura, Takeji
Kimura, Takefumi
Joshita, Satoru
Hirohara, Junko
Nakano, Toshiaki
Komori, Atsumasa
Tanaka, Atsushi
Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
title Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
title_full Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
title_fullStr Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
title_full_unstemmed Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
title_short Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
title_sort prognostic utility of albumin-bilirubin grade in japanese patients with primary biliary cholangitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976453/
https://www.ncbi.nlm.nih.gov/pubmed/36873419
http://dx.doi.org/10.1016/j.jhepr.2022.100662
work_keys_str_mv AT yamashitayuki prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT umemuratakeji prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT kimuratakefumi prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT joshitasatoru prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT hiroharajunko prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT nakanotoshiaki prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT komoriatsumasa prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis
AT tanakaatsushi prognosticutilityofalbuminbilirubingradeinjapanesepatientswithprimarybiliarycholangitis